ATE309332T1 - Unsterbliche retinalzellinien und deren anwendungen - Google Patents

Unsterbliche retinalzellinien und deren anwendungen

Info

Publication number
ATE309332T1
ATE309332T1 AT97920791T AT97920791T ATE309332T1 AT E309332 T1 ATE309332 T1 AT E309332T1 AT 97920791 T AT97920791 T AT 97920791T AT 97920791 T AT97920791 T AT 97920791T AT E309332 T1 ATE309332 T1 AT E309332T1
Authority
AT
Austria
Prior art keywords
retinal
primary
cell lines
lines
derived
Prior art date
Application number
AT97920791T
Other languages
English (en)
Inventor
John Greenwood
Peter Adamson
Raymond Lund
Original Assignee
Neurotech Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurotech Sa filed Critical Neurotech Sa
Application granted granted Critical
Publication of ATE309332T1 publication Critical patent/ATE309332T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0621—Eye cells, e.g. cornea, iris pigmented cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00—Use of cells in diagnostics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/04—Immortalised cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Neurology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Neurosurgery (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Prostheses (AREA)
AT97920791T 1996-04-19 1997-04-18 Unsterbliche retinalzellinien und deren anwendungen ATE309332T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9604964A FR2747690B1 (fr) 1996-04-19 1996-04-19 Lignees immortalisees de cellules retiniennes et leurs applications au traitement de differents troubles primaires ou secondaires ophtalmologiques ou neurologiques
PCT/FR1997/000709 WO1997040139A1 (fr) 1996-04-19 1997-04-18 Lignees immortalisees de cellules retiniennes et leurs applications

Publications (1)

Publication Number Publication Date
ATE309332T1 true ATE309332T1 (de) 2005-11-15

Family

ID=9491398

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97920791T ATE309332T1 (de) 1996-04-19 1997-04-18 Unsterbliche retinalzellinien und deren anwendungen

Country Status (10)

Country Link
US (1) US6183735B1 (de)
EP (1) EP0833895B1 (de)
JP (1) JPH11508142A (de)
AT (1) ATE309332T1 (de)
AU (1) AU725173B2 (de)
CA (1) CA2225520A1 (de)
DE (1) DE69734555D1 (de)
FR (1) FR2747690B1 (de)
NZ (1) NZ329360A (de)
WO (1) WO1997040139A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6878544B2 (en) * 1996-04-19 2005-04-12 Neurotech Sa Retinal cell lines with extended life-span and their applications
AU1404400A (en) * 1998-11-30 2000-06-19 Neurotech Sa Mammalian non-neuronal cells that are modified to store and release a neurotransmitter
FR2787464B1 (fr) * 1998-12-21 2003-01-10 Neurotech Compositions pharmaceutiques comprenant des cellules endotheliales immortalisees pour la detection et/ou le traitement des sources angiogeniques et tout particulierement des cancers
FR2787463B1 (fr) * 1998-12-21 2001-03-30 Neurotech Preparation de cellules de mammifere eventuellement transfectees avec un gene codant pour une substance active et les compositions les contenant
AU2003249227A1 (en) * 2002-07-12 2004-02-02 University Of Washington Methods and systems for extended in vitro culture of neuronal cells
GB0328021D0 (en) 2003-12-03 2004-01-07 Inst Of Ophthalmology Method
WO2007094301A1 (ja) * 2006-02-14 2007-08-23 Senju Pharmaceutical Co., Ltd. 硝子体細胞株
CA2681850C (en) * 2007-04-20 2013-07-23 Acucela Inc. Styrenyl derivative compounds for treating ophthalmic diseases and disorders
RU2470910C9 (ru) 2007-06-29 2013-05-20 Акьюсела, Инк. Соединения, представляющие собой алкинилфенильные производные, для лечения офтальмических заболеваний и расстройств
CN103553945B (zh) 2007-10-05 2015-01-07 奥克塞拉有限公司 用于治疗疾病的烷氧基化合物
EP2804605A4 (de) 2012-01-20 2015-07-08 Acucela Inc Substituierte heterocyclische verbindungen zur behandlung von krankheiten
CA2903483A1 (en) 2013-03-12 2014-10-09 Acucela Inc. Substituted 3-phenylpropylamine derivatives for the treatment of ophthalmic diseases and disorders

Also Published As

Publication number Publication date
US6183735B1 (en) 2001-02-06
CA2225520A1 (fr) 1997-10-30
FR2747690A1 (fr) 1997-10-24
FR2747690B1 (fr) 1998-06-12
NZ329360A (en) 1999-05-28
AU725173B2 (en) 2000-10-05
AU2704197A (en) 1997-11-12
WO1997040139A1 (fr) 1997-10-30
JPH11508142A (ja) 1999-07-21
DE69734555D1 (de) 2005-12-15
EP0833895B1 (de) 2005-11-09
EP0833895A1 (de) 1998-04-08

Similar Documents

Publication Publication Date Title
WO2001081551A3 (en) Retinal pigment epithelial cell lines with extended life-span and their applications
Oakeley et al. Developmental changes in DNA methylation of the two tobacco pollen nuclei during maturation
Altmann et al. Transcriptional activation by EBV nuclear antigen 1 is essential for the expression of EBV's transforming genes
Alani et al. Immortalization of primary human keratinocytes by the helix–loop–helix protein, Id-1
Momma et al. Get to know your stem cells
ATE309332T1 (de) Unsterbliche retinalzellinien und deren anwendungen
Preskey et al. Synthetically modified mRNA for efficient and fast human iPS cell generation and direct transdifferentiation to myoblasts
DE3889665D1 (de) Serumfreie wachstumsmedien für insektenzellen und expression von produkten damit.
CN110904051B (zh) 人源听神经瘤永生化细胞系、制备方法及其应用
DE60230774D1 (de) Isolierung von nervenstammzellen unter verwendung von gangliosiden und anderen oberflächenmarkern
Shur et al. Differential gene expression of cultured human osteoblasts
AU2002361797A1 (en) Cell lines with latent immunodeficiency virus and methods of use thereof
Wright Control of differentiation in heterokaryons and hybrids involving differentiation-defective myoblast variants.
Inoue et al. Establishment of three types of immortalized human skin stem cell lines derived from the single donor
Janz et al. CRISPR/Cas9-edited PKP2 knock-out (JMUi001-A-2) and DSG2 knock-out (JMUi001-A-3) iPSC lines as an isogenic human model system for arrhythmogenic cardiomyopathy (ACM)
Zhao et al. Pim-1 kinase cooperates with serum signals supporting mesenchymal stem cell propagation
Tang et al. Generation of a Bag1 homozygous knockout mouse embryonic stem cell line using CRISPR/Cas9
Raptis et al. Neoplastic transformation assays
Djojosubroto et al. Chromosomal number aberrations and transformation in adult mouse retinal stem cells in vitro
Shams Najafabadi et al. Isolation, Characterization, and Establishment of Spontaneously Immortalized Cell Line HRPE‐2S With Stem Cell Properties
Engler et al. Comparison of non-viral methods to genetically modify and enrich populations of primary human corneal endothelial cells
Sabourin et al. Transfer of the Herpes simplex thymidine kinase gene from human cells to mouse cells by means of metaphase chromosomes
Packard et al. A method for the establishment and long-term maintenance of in vitro monocytic cultures with functional and morphological homogeneity
Yanai et al. Retinal therapy with induced pluripotent stem cells; leading the way to human clinical trials
Hohenwarter et al. Expression of SV40 tumour antigens enables human endothelial cells to grow independently from foetal calf serum and exogenous growth factors

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties